Tower Research Capital (TRC)’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$161K Buy
2,898
+2,171
+299% +$117K ﹤0.01% 1793
2025
Q4
$35.2K Sell
727
-1,213
-63% -$47.3K ﹤0.01% 2692
2025
Q3
$59.4K Sell
1,940
-224
-10% -$5.14K ﹤0.01% 2391
2025
Q2
$48K Buy
2,164
+1,377
+175% +$28.8K ﹤0.01% 3012
2025
Q1
$14.6K Sell
787
-1,910
-71% -$31.9K ﹤0.01% 3277
2024
Q4
$35.7K Buy
2,697
+1,531
+131% +$37.1K ﹤0.01% 2784
2024
Q3
$39.1K Sell
1,166
-12,168
-91% -$416K ﹤0.01% 2862
2024
Q2
$334K Buy
13,334
+12,087
+969% +$281K 0.01% 1660
2024
Q1
$28.1K Sell
1,247
-19,275
-94% -$456K ﹤0.01% 2707
2023
Q4
$440K Buy
20,522
+16,926
+471% +$292K 0.01% 1469
2023
Q3
$64.6K Buy
3,596
+2,565
+249% +$48.9K ﹤0.01% 2335
2023
Q2
$21K Buy
1,031
+169
+20% +$3.43K ﹤0.01% 3341
2023
Q1
$19K Buy
862
+433
+101% +$10.5K ﹤0.01% 3469
2022
Q4
$13K Sell
429
-2,702
-86% -$76.3K ﹤0.01% 3571
2022
Q3
$80K Sell
3,131
-10,707
-77% -$251K ﹤0.01% 2753
2022
Q2
$281K Buy
13,838
+13,219
+2,136% +$293K 0.01% 1528
2022
Q1
$15K Sell
619
-1,534
-71% -$46.4K ﹤0.01% 3793
2021
Q4
$74K Buy
2,153
+1,621
+305% +$51.4K ﹤0.01% 2446
2021
Q3
$14K Sell
532
-868
-62% -$22K ﹤0.01% 4019
2021
Q2
$37K Sell
1,400
-3,566
-72% -$85.5K ﹤0.01% 3274
2021
Q1
$107K Buy
4,966
+3,875
+355% +$97.8K ﹤0.01% 2537
2020
Q4
$23K Sell
1,091
-3,577
-77% -$86.9K ﹤0.01% 3768
2020
Q3
$69K Buy
4,668
+1,934
+71% +$34.9K ﹤0.01% 3392
2020
Q2
$61K Buy
+2,734
New +$50K ﹤0.01% 2888
2020
Q1
Sell
-2,419
Closed -$39K 3000
2019
Q4
$39K Buy
2,419
+535
+28% +$12.7K ﹤0.01% 1482
2019
Q3
$66K Buy
+1,884
New +$89.6K ﹤0.01% 1593
2018
Q3
Sell
-440
Closed -$31K 3727
2018
Q2
$31K Sell
440
-1,755
-80% -$147K ﹤0.01% 2141
2018
Q1
$228K Buy
+2,195
New +$247K 0.02% 818
2017
Q4
Sell
-776
Closed -$27K 3479
2017
Q3
$27K Buy
+776
New +$20.9K ﹤0.01% 2515
2017
Q2
Sell
-50
Closed -$1K 2662
2017
Q1
$1K Buy
+50
New +$1.17K ﹤0.01% 2755

Other funds holding ANAB